Publications
Journal Article (6)
1.
Journal Article
9 (1), 201 (2014)
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases 2.
Journal Article
24 (11), pp. 1003 - 1017 (2014)
Selected items from the Charcot-Marie-Tooth (CMT) neuropathy score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. Neuromuscular Disorders 3.
Journal Article
34 (44), pp. 14506 - 14516 (2014)
Annexin A2 regulates TRPA1-dependent nociception. Journal of Neuroscience 4.
Journal Article
20 (9), pp. 1055 - 1061 (2014)
Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine 5.
Journal Article
94 (4), pp. 533 - 546 (2014)
Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. The American Journal of Human Genetics 6.
Journal Article
62 (2), pp. 217 - 232 (2014)
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia